Marketing-authorisation holder Β· Canada
Taro Pharmaceuticals Inc
287 medicines in 1 country, as authorisation holder.
Loading your pageβ¦
Marketing-authorisation holder Β· Canada
287 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1β25 of 287
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ANTI-ITCH CREAM2 % Β· Cream | Diphenhydramine | Canada | Marketed | 2007 |
| ANTI-ITCH PLUS CREAM2 % + 0.1 % Β· Cream | Diphenhydramine, Zinc | Canada | Authorised | |
| ANTIBIOTIC CREAM FOR KIDS0.25 mg / g + 50 mg / g + 10000 unit / g Β· Cream | Gramicidin, Lidocaine, Polymyxin b | Canada | Marketed | 2009 |
| ANTIBIOTIC OINTMENT USP500 unit / g + 10000 unit / g Β· Ointment | Bacitracin, Polymyxin b | Canada | Marketed | 2002 |
| ANTIBIOTIC PLUS PAIN RELIEF CREAM0.25 mg / g + 50 mg / g + 10000 unit / g Β· Cream | Gramicidin, Lidocaine, Polymyxin b | Canada | Marketed | 2009 |
| BETADERM CRM 0.05%0.05 % Β· Cream | Betamethasone | Canada | Marketed | 1979 |
| BETADERM CRM 0.1%0.1 % Β· Cream | Betamethasone | Canada | Marketed | 1979 |
| BETADERM LOTION 0.1%0.1 % Β· Lotion | Betamethasone | Canada | Marketed | 1979 |
| BETADERM ONT 0.05%0.05 % Β· Ointment | Betamethasone | Canada | Marketed | 1979 |
| BETADERM ONT 0.1%0.1 % Β· Ointment | Betamethasone | Canada | Marketed | 1988 |
| CLOTRIMADERM TOPICAL1 % Β· Cream | Clotrimazole | Canada | Marketed | 1988 |
| CLOTRIMADERM TOPICAL SOLUTION 1% USP10 mg / ml Β· Liquid | Clotrimazole | Canada | Authorised | |
| CLOTRIMADERM VAGINAL 32 % / w/w Β· Cream | Clotrimazole | Canada | Marketed | 1989 |
| CLOTRIMADERM VAGINAL 61 % / w/w Β· Cream | Clotrimazole | Canada | Marketed | 1989 |
| CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM1 % / w/w Β· Cream | Clotrimazole | Canada | Marketed | 2018 |
| CLOTRIMAZOLE EXTERNAL CREAM1 % / w/w Β· Cream | Clotrimazole | Canada | Authorised | |
| CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM2 % / w/w Β· Cream | Clotrimazole | Canada | Marketed | 2021 |
| CLOTRIMAZOLE TOPICAL1 % Β· Cream | Clotrimazole | Canada | Marketed | 1996 |
| CLOTRIMAZOLE VAGINAL 32 % Β· Cream | Clotrimazole | Canada | Marketed | 1996 |
| CLOTRIMAZOLE VAGINAL 61 % Β· Cream | Clotrimazole | Canada | Marketed | 2005 |
| COMPLETE ANTIBIOTIC OINTMENT500 unit / g + 0.25 mg / g + 50 mg / g + 10000 unit / g Β· Ointment | Bacitracin, Gramicidin, Lidocaine, Polymyxin b | Canada | Marketed | 2009 |
| EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE COMBI2 % + 150 mg Β· Capsule, Cream | Clotrimazole, Fluconazole | Canada | Marketed | 2022 |
| FLUCONAZOLE 150150 mg Β· Capsule | Fluconazole | Canada | Authorised | |
| INFANTS' IBUPROFEN ORAL SUSPENSION40 mg / ml Β· Drops | Ibuprofen | Canada | Authorised | |
| MENβS HAIR REGROWTH TREATMENT5 % / w/w Β· Aerosol (Foam) | Minoxidil | Canada | Marketed | 2025 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 287 | 214 | 73 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.